XW: Investigation, Methodology, Writing original draft
Should issues from long-term impacts arise, regulatory bodies like the FDA may need to reevaluate and possibly withdraw their approval, affecting both drug availability and the stock valuations of the companies producing them
Cannot redeclare control with same name "grid_3_carousel_arrow_size"
Various retrospective studies have pointed to a protective effect of GLP-1 agonists in dementia, with some showing improvements of 40% to 70% compared to other drugs used to treat diabetes, but the new study offers an opportunity to test that hypothesis prospectively
One such study by McClean and colleagues [61] observed that liraglutide can cross the blood-brain barrier in substantial amounts and can prevent deficits in the water maze task performance and object recognition in AD model mice
Perhaps most importantly, the combination of GLP-1 for weight loss medications with exercise and proper nutrition appears to offer the best results